ArticleOphthalmology and therapy2026
In Vitro Bactericidal Activity of Propamidine 0.1% and Other Ophthalmic Antiseptics on Conjunctivitis and Blepharitis Strains.
Article in Ophthalmology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe aim of this study was to assess the in vitro antimicrobial activity of propamidine isethionate 0.1% ophthalmic solution and other topical antiseptics, including hexamidine di-isethionate 0.1%, cethexonium bromide 0.025%, and picloxydine hydrochloride 0.05%.
methodsAntibacterial activity was tested in vitro on five Gram-positive bacterial strains commonly found in conjunctivitis and/or blepharitis. Test products were applied at a concentration of 80% at 20 °C (in accordance with NF EN 1040) for contact periods of 2, 5, 10, and 15 min. After neutralization, surviving bacteria were cultured, and colony forming units (CFU) were counted. Antimicrobial efficacy was expressed as log reduction in CFU. Bactericidal activity was defined as a reduction > 5 log.
resultsAll tested antiseptics demonstrated antibacterial activity with variability in magnitude of their effects depending on the bacterial strain and contact time. Propamidine 0.1% showed rapid activity, achieving maximal log reduction within 2 min against Staphylococcus epidermidis, Streptococcus pneumoniae, and Propionibacterium acnes. Cethexonium bromide 0.025% exhibited the highest antibacterial activity, with bactericidal effects observed against Corynebacterium striatum, S. pneumoniae, and P. acnes; hexamidine 0.1% and picloxydine 0.05% showed more limited or inconsistent bactericidal activity.
conclusionAll tested antiseptics demonstrated measurable in vitro antibacterial activity against common pathogens associated with conjunctivitis and blepharitis. The observed variability in antimicrobial magnitude highlight the influence of bacterial strain and exposure conditions on antiseptic performance. These results support the potential clinical interest of ocular antiseptics, including propamidine 0.1% in the management of mild bacterial conjunctivitis and blepharitis, although confirmation under clinical conditions remains necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.